Elena Shagisultanova
7PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 05, 2024
Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancer.Anthony D Elias, Alyse W Staley, Monica Fornier
|Jun 26, 2023
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.Elena Shagisultanova, William Gradishar, Ursa Brown-Glaberman
|May 20, 2023
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.Anthony D Elias, Nicole S Spoelstra, Alyse W Staley
|Mar 31, 2022
PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.Aryana R Rasti, Amy Guimaraes-Young, Farrah Datko
|Nov 03, 2021
Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2.Elena Shagisultanova, Lyndsey S Crump, Michelle Borakove
|Jun 30, 2019
Combined inhibition of Aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer.Vladislav Korobeynikov, Michelle Borakove, Yayi Feng
Pageof 2
Frequent Collaborators
4 joint publications
Virginia F Borges
2 joint publications
Anthony D Elias
2 joint publications
Alyse W Staley
2 joint publications
Rosa I Gallagher
2 joint publications
Jennifer K Richer
1 joint publications
Jessica K Hall
1 joint publications
Benjamin A Harrison
1 joint publications
Traci R Lyons
1 joint publications
Amy Guimaraes-Young
1 joint publications
Dara L Aisner
